English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/88525
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE
Exportar a otros formatos:


Glycopyrrolate combinations for the treatment of respiratory diseases

AuthorsGuerra, Ángela CSIC; Campillo, Nuria E. CSIC ORCID ; Páez, Juan A. CSIC ORCID
Issue Date2006
PublisherAshley Publications
CitationExpert Opinion on Therapeutic Patents 16: 723- 728 (2006)
AbstractThis paper analyses three patents, published in 2005 by Sofotec GmbH & Co. KG, for the treatment of respiratory diseases that include asthma and chronic obstructive pulmonary disease (COPD). The patent applications claim the combination of anticholinergics and different bronchodilators or anti-inflamatories as β-mimetics, PDE4 inhibitors and glucocorticoids. © 2006 Informa UK Ltd.
Identifiersdoi: 10.1517/13543776.16.5.723
issn: 1354-3776
e-issn: 1744-7674
Appears in Collections:(IQM) Artículos
Files in This Item:
File Description SizeFormat 
accesoRestringido.pdf15,38 kBAdobe PDFThumbnail
Show full item record
Review this work

Related articles:

WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.